Page 4 - மருந்துகள் பாலிஸீ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Overview Since the 2013 publication of the “Causality assessment of an adverse event following immunization (AEFI), user manual for the revised WHO classification”, there has been extensive global interest in adopting the new revised causality assessment methodology for vaccine pharmacovigilance systems. WHO provided technical support and helped build capacity in countries of all WHO Regions who wanted to use the revised methodology. An AEFI causality assessment software was developed, translated to six UN languages and made available online. Recently, the new methodology has been scientifically evaluated. In April 2017, WHO coordinated an India - Zimbabwe project entitled “Inter-country study to assess the inter-rater reliability of the WHO AEFI causality assessment methodology and the utility of the new WHO AEFI causality assessment software”. The quantitative aspect of the study determined that there was realistic agreement between assessors in their findings

Clinical researchPharmaceuticals policyWorld health organizationHealthcare qualityமருத்துவ ஆராய்ச்சிமருந்துகள் பாலிஸீஉலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்சுகாதாரம் தரம்